Gemcitabine in NK/T Cell Lymphoma
NCT01660568 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2013-02-13
Summary
We retrospectively review patients with refractory or relapsed ENKL who received a gemcitabine-containing regimen
Conditions
- NK/T Cell Lymphoma
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
Immunotherapy in Lymphoma
NCT06796517 ·Status: RECRUITING
-
Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma
NCT01341119 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012
NCT06565689 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type
NCT02927925 ·Status: COMPLETED ·Phase: PHASE2
-
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
NCT04061850 ·Status: COMPLETED
-
Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
NCT03021057 ·Status: UNKNOWN ·Phase: PHASE2
-
International Extranodal NK/T-cell Lymphoma Project
NCT02386813 ·Status: COMPLETED
-
Safety and Efficacy of BKM120 in Relapsed and Refractory NHL
NCT01693614 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
NCT01802138 ·Status: COMPLETED ·Phase: NA
-
A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT05623982 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
NCT01676558 ·Status: UNKNOWN ·Phase: PHASE2
-
Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults
NCT01809600 ·Status: COMPLETED
-
Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
NCT00846157 ·Status: UNKNOWN ·Phase: PHASE3
-
The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)
NCT01266668 ·Status: COMPLETED
-
Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL
NCT00655837 ·Status: COMPLETED ·Phase: PHASE1
-
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
NCT00374699 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma
NCT02585947 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
NCT00001237 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia
NCT00265915 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III
NCT03117036 ·Status: RECRUITING
-
Cohort Study for Gastric MALT Lymphoma
NCT06454149 ·Status: RECRUITING
-
Tofacitinib Combined With Chidamide in R/R ENKTCL
NCT03598959 ·Status: UNKNOWN ·Phase: PHASE2
-
Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research
NCT06049381 ·Status: NOT_YET_RECRUITING
-
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
NCT06541327 ·Status: RECRUITING
-
RICE-ibrutinib in Relapsed DLBCL
NCT02955628 ·Status: UNKNOWN ·Phase: PHASE2